235 related articles for article (PubMed ID: 16476709)
1. Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions.
Douglas KM; Ladoyanni E; Treharne GJ; Hale ED; Erb N; Kitas GD
Ann Rheum Dis; 2006 Oct; 65(10):1341-5. PubMed ID: 16476709
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
Lee HH; Song IH; Friedrich M; Gauliard A; Detert J; Röwert J; Audring H; Kary S; Burmester GR; Sterry W; Worm M
Br J Dermatol; 2007 Mar; 156(3):486-91. PubMed ID: 17300238
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis in dermatology.
Hata T; Kavanaugh A
Clin Dermatol; 2006; 24(5):430-7. PubMed ID: 16966022
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis: a review of the cutaneous manifestations.
Sayah A; English JC
J Am Acad Dermatol; 2005 Aug; 53(2):191-209; quiz 210-2. PubMed ID: 16021111
[TBL] [Abstract][Full Text] [Related]
5. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects.
Xue Y; Cohen JM; Wright NA; Merola JF
Am J Clin Dermatol; 2016 Apr; 17(2):147-62. PubMed ID: 26649439
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.
Haroon M; Adeeb F; Devlin J; O Gradaigh D; Walker F
Int J Rheum Dis; 2011 Aug; 14(3):255-60. PubMed ID: 21816021
[TBL] [Abstract][Full Text] [Related]
7. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
[TBL] [Abstract][Full Text] [Related]
8. Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.
Vila AT; Puig L; Fernández-Figueras MT; Laiz AM; Vidal D; Alomar A
Br J Dermatol; 2005 Aug; 153(2):417-23. PubMed ID: 16086759
[TBL] [Abstract][Full Text] [Related]
9. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.
Wolfe F; Michaud K; Chakravarty EF
Rheumatology (Oxford); 2006 Nov; 45(11):1370-5. PubMed ID: 17003175
[TBL] [Abstract][Full Text] [Related]
10. Impaired cutaneous cell-mediated immunity in newly diagnosed rheumatoid arthritis.
Coaccioli S; Di Cato L; Marioli D; Patucchi E; Pizzuti C; Ponteggia M; Puxeddu A
Panminerva Med; 2000 Dec; 42(4):263-6. PubMed ID: 11294089
[TBL] [Abstract][Full Text] [Related]
11. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions.
Kinder AJ; Hassell AB; Brand J; Brownfield A; Grove M; Shadforth MF
Rheumatology (Oxford); 2005 Jan; 44(1):61-6. PubMed ID: 15611303
[TBL] [Abstract][Full Text] [Related]
12. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis patients' education - contents and methods.
Mäkeläinen P; Vehviläinen-Julkunen K; Pietilä AM
J Clin Nurs; 2007 Nov; 16(11C):258-67. PubMed ID: 17931319
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
Anić B; Cikes N
Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.
Hellgren K; Iliadou A; Rosenquist R; Feltelius N; Backlin C; Enblad G; Askling J; Baecklund E
Ann Rheum Dis; 2010 Apr; 69(4):654-9. PubMed ID: 19439429
[TBL] [Abstract][Full Text] [Related]
16. Skin disorders associated with rheumatic disease.
Kaminski MJ
Clin Podiatr Med Surg; 1996 Jan; 13(1):139-53. PubMed ID: 8849938
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients.
Tragulpiankit P; Chulavatnatol S; Rerkpattanapipat T; Janwityanujit S; Somjarit S; Sirikhedgon U
Int J Rheum Dis; 2012 Jun; 15(3):315-21. PubMed ID: 22709494
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.
Karvounaris SA; Sidiropoulos PI; Papadakis JA; Spanakis EK; Bertsias GK; Kritikos HD; Ganotakis ES; Boumpas DT
Ann Rheum Dis; 2007 Jan; 66(1):28-33. PubMed ID: 16793841
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
[TBL] [Abstract][Full Text] [Related]
20. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
de Klerk E; van der Heijde D; Landewé R; van der Tempel H; Urquhart J; van der Linden S
J Rheumatol; 2003 Jan; 30(1):44-54. PubMed ID: 12508389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
